- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| Do | NeuroOne Medical Technologies Corporation: NeuroOne Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF Trigeminal Nerve Ablation System | 2 | GlobeNewswire (USA) | ||
| 22.10. | NeuroOne secures first pharma order for drug delivery platform | 4 | Investing.com | ||
| 22.10. | NeuroOne Medical Technologies Corporation: NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED' Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program | 3 | GlobeNewswire (USA) | ||
| 08.10. | NeuroOne erhält 200.000 USD aus NIH-Forschungszuschuss für Neurotransmitter-Technologie | 1 | Investing.com Deutsch | ||
| 05.10. | NeuroOne: Vorläufiger Q4-Umsatz steigt auf 3,8 Millionen US-Dollar | 3 | Investing.com Deutsch | ||
| 05.10. | NeuroOne Medical Technologies Corporation: NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order | 192 | GlobeNewswire (Europe) | Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million Preliminary Full-Year Product Revenue Up 15.6% to $10.5 Million, at the Top of Guidance Range EDEN PRAIRIE, Minn., Oct. 05, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 05.10. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 10.09. | NeuroOne auf der Moody Capital Konferenz: Dünnschicht-Plattform soll Wachstum vorantreiben | - | Investing.com Deutsch | ||
| 27.08. | EQS-News: NeuroOne Medical Technologies: NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED Platform | 615 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED Platform 27.08.2026... ► Artikel lesen | |
| 27.08. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 21.08. | NeuroOne: Product Revenue Jumps 105% As Gross Margin Expands Nearly 20 Percentage Points In Fiscal Q3 2025 | 1 | pulse2.com | ||
| 13.08. | NeuroOne expects FY2026 product orders of about $11.2M while working to clear backlog by Q4 2026 | 2 | Seeking Alpha | ||
| 13.08. | Earnings Call: NeuroOne Medical steigert Umsatz im dritten Quartal, Aktie gibt dennoch nach | 2 | Investing.com Deutsch | ||
| 13.08. | NeuroOne Medical Technologies GAAP EPS of -$0.28 misses by $0.06, revenue of $2M misses by $0.55M | 1 | Seeking Alpha | ||
| 13.08. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.08. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | - | SEC Filings | ||
| 13.08. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% | 1.465 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins... ► Artikel lesen | |
| 11.08. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification | 1.560 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification 11.08.2026 / 14:35 CET/CEST
The issuer is... ► Artikel lesen | |
| 03.08. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time | 366 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m.... ► Artikel lesen | |
| 30.07. | EQS-News: NeuroOne Medical Technologies: NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED Platform | 536 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Science
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED Platform... ► Artikel lesen |
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 60,34 | +0,20 % | BrightSpring Health Services, Inc. - 10-Q, Quarterly Report | ||
| LIFESTANCE HEALTH GROUP | 13,635 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,920 | -1,33 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,020 | -0,50 % | Alignment Healthcare Q3 2026 Earnings Call Transcript | ||
| SIEMENS HEALTHINEERS | 43,190 | +0,70 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,765 | +1,63 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| HEARTFLOW | 60,55 | +0,03 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 114,75 | -0,08 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| GENEDX | 70,98 | -0,06 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CONCENTRA GROUP | 41,250 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| GERRESHEIMER | 33,040 | +3,57 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,420 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Schedule 14A Preliminary Proxy Statement | ||
| STARLING ONCOLOGY INSTITUTE | 6,650 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| MIMEDX | 3,975 | +0,13 % | Mizuho cuts MiMedx stock price target on wound segment weakness | ||
| KESTRA MEDICAL TECHNOLOGIES | 30,580 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen |
NEUROONE MEDICAL TECHNOLOGIES CORPORATION gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,970 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.